Macular Hole Clinical Trials

• Full Thickness Macular Hole and Internal Limiting Membrane Peeling Study
  ClinicalTrials.gov Identifier: NCT00286507 - Recruiting
  Stage 2 or 3 Full Thickness Macular Hole
  
• Indocyanine Green or Trypan Blue for Delamination of the Internal Limiting Membrane in Macular Hole Surgery
  ClinicalTrials.gov Identifier: NCT00419185 - Completed
  Idiopathic Macular Hole
  
• Trial of Prognostic Factors and Surgical Methods for the Treatment of Idiopathic Macular Holes
  ClinicalTrials.gov Identifier: NCT00302328 - Active, not recruiting
  Idiopathic Macular Hole Stage 2 and 3
  
• Internal Limiting Membrane Peeling for Large Macular Holes
  ClinicalTrials.gov Identifier: NCT00190190 - Recruiting
  Macular Hole
  
• Alleviated Positioning for Small Macular Holes
  ClinicalTrials.gov Identifier: NCT00190164 - Recruiting
  Macular Hole
  
• Study of OT-551 Eye Drops to Prevent or Delay Progression of Nuclear Cataracts Following Vitreous Removal
  ClinicalTrials.gov Identifier: NCT00333060 - Active, not recruiting
  Epiretinal Membrane; Macular Hole
  
• Membrane Blue Versus Infracyanine Green
  ClinicalTrials.gov Identifier: NCT00555269 - Completed
  Macular Pucker; Macular Hole
  
• A Study to Evaluate Retisert in the Treatment of Patients with the "wet" form of Age-Related Macular Degeneration
  ClinicalTrials.gov Identifier: NCT00032396 - Active, not recruiting
  Macular Degeneration
  
• Extension Study of rhuFab V2 in Subjects with Neovascular Age-Related Macular Degeneration (AMD)
  ClinicalTrials.gov Identifier: NCT00095433 - Active, not recruiting
  Macular Degeneration
  
• The Effect of Eggs and Egg Products on the Macular Pigment
  ClinicalTrials.gov Identifier: NCT00527553 - Enrolling by invitation
  Age-Related Macular Degeneration
  
• Age-Related Macular Degeneration and Cataract
  ClinicalTrials.gov Identifier: NCT00001312 - Active, not recruiting
  Cataract; Macular Degeneration
  
• Preventing Depression in Patients with Macular Degeneration
  ClinicalTrials.gov Identifier: NCT00042211 - Active, not recruiting
  Depression; Macular Degeneration
  
• Rheopheresis Blood Filtration Study for the Treatment of Dry Age-Related Macular Degeneration (AMD)
  ClinicalTrials.gov Identifier: NCT00078221 - Active, not recruiting
  Macular Degeneration
  
• MPOD in Macular Teleangiectasia Following Supplementation of Lutein and Zeaxanthin
  ClinicalTrials.gov Identifier: NCT00568828 - Recruiting
  Macular Teleangiectasia; Macular Pigment
  
• Open Label Extension of a Clinical Trial of Intravitreal Triamcinolone for Diabetic Macular Oedema-TDMX Study
  ClinicalTrials.gov Identifier: NCT00148330 - Active, not recruiting
  Diabetic macular oedema
  
• Macular Photocoagulation Study (MPS)
  ClinicalTrials.gov Identifier: NCT00000158 - Active, not recruiting
  Choroidal Neovascularization; Macular Degeneration; Histoplasmosis
  
• Randomized Trial of Beta-Carotene and Macular Degeneration
  ClinicalTrials.gov Identifier: NCT00000152 - Active, not recruiting
  Macular Degeneration
  
• A Study of an Encapsulated Cell Technology (ECT) Implant for Patients With Atrophic Macular Degeneration
  ClinicalTrials.gov Identifier: NCT00447954 - Active, not recruiting
  Macular Degeneration
  
• Study of Sirna-027 in Patients With Age-Related Macular Degeneration
  ClinicalTrials.gov Identifier: NCT00495742 - Active, not recruiting
  Macular Degeneration; Choroidal Neovascularization
  
• Anecortave Acetate in Patients With Exudative Age-Related Macular Degeneration (AMD)
  ClinicalTrials.gov Identifier: NCT00299507 - Active, not recruiting
  Macular Degeneration
  
• Safety and Efficacy Study of Small Interfering RNA Molecule (Cand5) to Treat Wet Age-Related Macular Degeneration
  ClinicalTrials.gov Identifier: NCT00259753 - Active, not recruiting
  Macular Degeneration
  
• Safety and Tolerability of Intravitreal Administration of Vascular Endothelial Growth Factor (VEGF) Trap in Patients With Neovascular Age-Related Macular Degeneration (AMD)
  ClinicalTrials.gov Identifier: NCT00320775 - Active, not recruiting
  Macular Degeneration
  
• Treatment of Age-Related Macular Degeneration With Anecortave Acetate
  ClinicalTrials.gov Identifier: NCT00211458 - Active, not recruiting
  Macular Degeneration
  
• Safety and Efficacy of Repeated Intravitreal Administration of Vascular Endothelial Growth Factor (VEGF) Trap in Patients With Wet Age-Related Macular Degeneration (AMD)
  ClinicalTrials.gov Identifier: NCT00320788 - Active, not recruiting
  Macular Degeneration
  
• Pegaptanib Sodium (Macugen) Compared to Sham Injection in Patients with Diabetic Macular Edema (DME) Involving the Center of the Macula
  ClinicalTrials.gov Identifier: NCT00148811 - Active, not recruiting
  Diabetic Macular Edema
  
• A Study of the Safety and Efficacy of a New Treatment in Combination With Laser for Macular Edema Resulting From Diabetic Macular Edema
  ClinicalTrials.gov Identifier: NCT00464685 - Recruiting
  Diabetic Macular Edema
  
• Double-Masked Study of Photrex (Rostaporfin) Photodynamic Therapy in the Treatment of Age-Related Macular Degeneration
  ClinicalTrials.gov Identifier: NCT00157976 - Recruiting
  Macular Degeneration
  
• Submacular Surgery Trials (SST)
  ClinicalTrials.gov Identifier: NCT00000150 - Active, not recruiting
  Macular Degeneration; Histoplasmosis
  
• Genetic Factors in Age-Related Macular Degeneration
  ClinicalTrials.gov Identifier: NCT00058695 - Recruiting
  Macular Degeneration
  
• Fluocinolone Acetonide Implant Compared to Sham Injection in Patients With Diabetic Macular Edema
  ClinicalTrials.gov Identifier: NCT00344968 - Active, not recruiting
  Diabetic Macular Edema
  
• Use of Intravitreal Bevacizumab in Patients With Diffuse Diabetic Macular Edema
  ClinicalTrials.gov Identifier: NCT00417716 - Active, not recruiting
  Diabetes Mellitus Type 2; Diabetic Macular Edema
  
• Short-Term Effects of Intravitreal Bevacizumab and Trimacinolone in Patients With Diabetic Macular Edema
  ClinicalTrials.gov Identifier: NCT00563940 - Active, not recruiting
  Diabetic Macular Edema
  
• A Pilot Study of Laser Photocoagulation for Diabetic Macular Edema
  ClinicalTrials.gov Identifier: NCT00071773 - Active, not recruiting
  Diabetic Macular Edema
  
• RESOLVE: Safety and Efficacy of Ranibizumab in Diabetic Macular Edema With Center Involvement
  ClinicalTrials.gov Identifier: NCT00284050 - Active, not recruiting
  Diabetic Macular Edema
  
• Ranibizumab (Lucentis) for Macular Edema Secondary to Vein Occlusions
  ClinicalTrials.gov Identifier: NCT00407355 - Active, not recruiting
  Macular Edema; Retinal Vein Occlusion
  
• Effect of Nepafenac on Post-Operative Macular Swelling Following Uncomplicated Cataract Surgery
  ClinicalTrials.gov Identifier: NCT00494494 - Recruiting
  Cystoid Macular Edema
  
• Effects of Sun Filters on Age-Related Macular Degeneration in People With Lens Implants
  ClinicalTrials.gov Identifier: NCT00487838 - Recruiting
  Age-Related Macular Changes; Age-Related Macular Degeneration; Cataract and IOL Surgery; Retinal Photochemistry
  
• Phase 1 Study of VEGF Trap in Patients With Diabetic Macular Edema
  ClinicalTrials.gov Identifier: NCT00320814 - Active, not recruiting
  Diabetic Macular Edema
  
• Intravitreal Triamcinolone Acetonide Versus Laser for Diabetic Macular Edema
  ClinicalTrials.gov Identifier: NCT00367133 - Active, not recruiting
  Diabetic Macular Edema
  
• A Pilot Study of Peribulbar Triamcinolone Acetonide for Diabetic Macular Edema
  ClinicalTrials.gov Identifier: NCT00369486 - Active, not recruiting
  Diabetic Macular Edema
  
• EXCITE - Efficacy and Safety of Ranibizumab in Patients With Subfoveal Choroidal Neovascularization (CNV) Secondary to Age-Related Macular Degeneration (ARMD)
  ClinicalTrials.gov Identifier: NCT00275821 - Active, not recruiting
  Age-Related Macular Degeneration
  
• Efficacy and Safety of Ranibizumab in Patients With Subfoveal Choroidal Neovascularization (CNV) Secondary to Age-Related Macular Degeneration (AMD)
  ClinicalTrials.gov Identifier: NCT00470678 - Active, not recruiting
  Choroidal Neovascularization; Macular Degeneration
  
• Quantification of Rising the Osmotic Pressure in Diabetic Intraretinal Fluid Accumulation (Diabetic Macular Oedema)
  ClinicalTrials.gov Identifier: NCT00333671 - Active, not recruiting
  Diabetic Macular Oedema
  
• Selective RPE Laser Treatment (SRT) for Various Macular Diseases
  ClinicalTrials.gov Identifier: NCT00403884 - Recruiting
  Age-Related Macular Degeneration; Diabetic Maculopathy; Central Serous Chorioretinopathy
  
• Bevacizumab Versus Combined Bevacizumab and Triamcinolone for Refractory Diabetic Macular Edema; a Randomized Clinical Trial
  ClinicalTrials.gov Identifier: NCT00370422 - Active, not recruiting
  Diabetic Macular Edema
  
• Intravitreal Triamcinolone Acetonide Versus Intravitreal Bevacizumab for Refractory Diabetic Macular Edema (IBEME Study)
  ClinicalTrials.gov Identifier: NCT00468351 - Active, not recruiting
  Diabetic Macular Edema
  
• A Multicentre Randomised Clinical Trial of Laser Treatment Plus Intravitreal Triamcinolone for Diabetic Macular Oedema
  ClinicalTrials.gov Identifier: NCT00148265 - Recruiting
  Diabetic macular oedema
  
• Effect of Ruboxistaurin on Clinically Significant Macular Edema
  ClinicalTrials.gov Identifier: NCT00133952 - Recruiting
  Diabetic Macular Edema
  
• Y402H Comlement Factor H Polymorphism and Age-Related Macular Degeneration in the Austrian Population
  ClinicalTrials.gov Identifier: NCT00533754 - Active, not recruiting
  Age-Related Macular Degeneration
  
• Randomized Trials of Vitamin Supplements and Eye Disease
  ClinicalTrials.gov Identifier: NCT00000161 - Active, not recruiting
  Macular Degeneration; Cataract
  
• A Trial to Assess the Safety and Tolerability of Repeated Doses of Intravitreal Administration of Two VEGF Trap Formulations in Subjects With Neovascular Age Related Macular Degeneration
  ClinicalTrials.gov Identifier: NCT00383370 - Active, not recruiting
  Neovascular Age Related Macular Degeneration
  
• Age-Related Eye Disease Study (AREDS)
  ClinicalTrials.gov Identifier: NCT00000145 - Active, not recruiting
  Macular Degeneration; Cataract; Lens Opacities
  
• Safety Study of 16.5mg (3.3%) CGC-11047 Injected Once Every 2 Weeks vs. Once Every 4 Weeks in Patients With CNV Due to Age Related Macular Degeneration
  ClinicalTrials.gov Identifier: NCT00446654 - Active, not recruiting
  Age Related Macular Degeneration
  
• A Study of the Safety and Efficacy of a New Treatment for Macular Edema Resulting From Branch Retinal Vein Occlusion
  ClinicalTrials.gov Identifier: NCT00308477 - Recruiting
  Macular Degeneration; Macular Edema; Branch Retinal Vein Occlusion
  
• Efficacy and Safety Study of Intravitreal Triamcinolone to Treat Diffuse Diabetic Macular Edema
  ClinicalTrials.gov Identifier: NCT00309192 - Recruiting
  Diabetes Mellitus; Macular Edema
  
• Safety and Efficacy of ATG003 in Patients With Wet Age-Related Macular Degeneration (AMD)
  ClinicalTrials.gov Identifier: NCT00414206 - Recruiting
  Macular Degeneration
  
• A Study of Strontium90 Beta Radiation With Lucentis to Treat Age-Related Macular Degeneration
  ClinicalTrials.gov Identifier: NCT00454389 - Recruiting
  Macular Degeneration
  
• Phase 3 Study to evaluate Anecortave Acetate vs. Visudyne for the treatment of the wet form of AMD.
  ClinicalTrials.gov Identifier: NCT00041483 - Active, not recruiting
  Macular Degeneration
  
• Evaluation Of Safety And Efficacy Of 0.3 Mg/Eye Macugen In Patients With Small Age-Related Macular Degeneration Lesions
  ClinicalTrials.gov Identifier: NCT00324116 - Recruiting
  Macular Degeneration
  
• Pneumatic Retinopexy Versus Vitrectomy With Gas for Retinal Detachment Due to Myopic Macular Hole
  ClinicalTrials.gov Identifier: NCT00485199 - Completed
  Retinal Detachment
  
• Clinical Study Of EYE001 For Wet-Type Age-Related Macular Degeneration
  ClinicalTrials.gov Identifier: NCT00239928 - Recruiting
  Macular Degeneration
  
• Infliximab, Sirolimus and Daclizumab to Treat Age-Related Macular Degeneration
  ClinicalTrials.gov Identifier: NCT00304954 - Recruiting
  Macular Degeneration; Neovascularization
  
• Safety Of Patients Receiving Macugen For Neovascular Age Related Macular Degeneration
  ClinicalTrials.gov Identifier: NCT00460408 - Recruiting
  Macular Degeneration
  
• Ranibizumab for Branch Retinal Vein Occlusion Associated Macular Edema Study (RABAMES)
  ClinicalTrials.gov Identifier: NCT00562406 - Recruiting
  Macular Edema
  
• Study To Determine Safety/Efficacy of Lucentis For Treatment Of Retinal Angiomatous Proliferation Secondary To Age Related Macular Degeneration
  ClinicalTrials.gov Identifier: NCT00395707 - Recruiting
  Macular Degeneration
  
• A Study of Ranibizumab Injection in Subjects With Clinically Significant Macular Edema With Center Involvement Secondary to Diabetes Mellitus (RISE)
  ClinicalTrials.gov Identifier: NCT00473330 - Recruiting
  Macular Edema
  
• A Study of Ranibizumab Injection in Subjects With Clinically Significant Macular Edema With Center Involvement Secondary to Diabetes Mellitus (RIDE)
  ClinicalTrials.gov Identifier: NCT00473382 - Recruiting
  Macular Edema
  
• A Randomized Study Comparing Ranibizumab to Sham in Patients With Macular Edema Secondary to CRVO
  ClinicalTrials.gov Identifier: NCT00567697 - Recruiting
  Central Retinal Vein Occlusion; Macular Edema
  
• Effect of Intravitreal Bevacizumab on Clinically Significant Macular Edema
  ClinicalTrials.gov Identifier: NCT00370669 - Recruiting
  Diabetic Macular Edema
  
• Intravitreal Bevacizumab (Avastin) for Pseudophakic Macular Edema (PME)
  ClinicalTrials.gov Identifier: NCT00406172 - Recruiting
  Cystoid Macular Edema
  
• Safety Study for Treatment of Wet Macular Degeneration Using the TheraSight(TM) Ocular Brachytherapy System
  ClinicalTrials.gov Identifier: NCT00100087 - Recruiting
  Macular Degeneration; Choroidal Neovascularization
  
• Combination Therapy for Neovascular Age Related Macular Degeneration
  ClinicalTrials.gov Identifier: NCT00447031 - Recruiting
  Macular Degeneration
  
• Oxidative Stress in Patients With Age-Related Macular Degeneration
  ClinicalTrials.gov Identifier: NCT00465400 - Recruiting
  Macular Degeneration
  
• Lucentis for Inflammatory Macular Edema Trial
  ClinicalTrials.gov Identifier: NCT00498355 - Recruiting
  Uveitis; Cytoid Macular Edema
  
• Systemic Avastin Therapy in Age-Related Macular Degeneration
  ClinicalTrials.gov Identifier: NCT00531024 - Recruiting
  Macular Degeneration
  
• A Phase II Study of Implants of Encapsulated Human NTC-201 Cells Releasing Ciliary Neurotrophic Factor (CNTF) in Participants With Visual Acuity Impairment Associated With Atrophic Macular Degeneration
  ClinicalTrials.gov Identifier: NCT00277134 - Active, not recruiting
  Visual Acuity Impairment; Atrophic Macular Degeneration
  
• Comparison of a Spectral OCT/SLO With the Stratus OCT for Imaging Various Retinal Pathologies
  ClinicalTrials.gov Identifier: NCT00408720 - Completed
  Macular Hole; RPE Detachment; Epiretinal Membrane; Posterior Vitreous Detachment
  
• A Study of the Safety and Efficacy of a New Treatment for Macular Edema Resulting From Retinal Vein Occlusion
  ClinicalTrials.gov Identifier: NCT00168298 - Active, not recruiting
  Macular Edema; Retinal Vein Occlusion
  
• A Study of the Safety and Efficacy of a New Treatment for Macular Edema Resulting From Retinal Vein Occlusion
  ClinicalTrials.gov Identifier: NCT00168324 - Active, not recruiting
  Macular Edema; Retinal Vein Occlusion
  
• An evaluation of safety and efficacy of Anecortave Acetate vs. placebo in patients with subfoveal choroidal neovascularization(CNV) due to wet age-related macular degeneration(AMD)
  ClinicalTrials.gov Identifier: NCT00051129 - Active, not recruiting
  Macular Degeneration; Maculopathy, Age-Related; Age-Related Maculopathies; Age-Related Maculopathy; Maculopathies, Age-Related
  
• Triple Therapy - PDT Plus IVD and Intravitreal Ranibizumab Versus Monotherapy - Intravitreal Ranibizumab Alone to Treat Age-Related Macular Degeneration.
  ClinicalTrials.gov Identifier: NCT00390208 - Active, not recruiting
  Age Related Macular Degeneration
  
• A Study to Evaluate Ranibizumab in Subjects With Choroidal Neovascularization (CNV) Secondary to Age-Related Macular Degeneration (AMD)
  ClinicalTrials.gov Identifier: NCT00251459 - Active, not recruiting
  Choroidal Neovascularization; Age-Related Macular Degeneration
  
• An evaluation of safety and efficacy of Anecortave Acetate versus placebo in patients with subfoveal CNV due to exudative AMD.
  ClinicalTrials.gov Identifier: NCT00058994 - Active, not recruiting
  Macular Degeneration; Maculopathy, Age-Related
  
• SUSTAIN - Study of Ranibizumab in Patients With Subfoveal Choroidal Neovascularization Secondary to Age-Related Macular Degeneration
  ClinicalTrials.gov Identifier: NCT00331864 - Active, not recruiting
  Age-Related Macular Degeneration; Choroidal Neovascularization
  
• Safety Study of Bromfenac Ophthalmic Solution in Subjects With Diffuse Diabetic Macular Edema (DME) Refractory to Laser
  ClinicalTrials.gov Identifier: NCT00491166 - Recruiting
  Diabetic Macular Edema
  
• Treatment of Bevacizumab and Triamcinolone in Treatment or Macular Edema Secondary to CRVO
  ClinicalTrials.gov Identifier: NCT00566761 - Recruiting
  Macular Edema; Central Retinal Vein Occlusion
  
• Study of Fenretinide in the Treatment of Geographic Atrophy Associated With Dry Age-Related Macular Degeneration
  ClinicalTrials.gov Identifier: NCT00429936 - Recruiting
  Macular Degeneration; Atrophy
  
• Changes in mfERG and as Gauge for Illness Activity and Macular Edema in Uveitis
  ClinicalTrials.gov Identifier: NCT00476593 - Recruiting
  Uveitis; Iritis; Macular Edema; Retinitis; Iridocyclitis
  
• Pharmacokinetic and Efficacy Study of Fluocinolone Acetonide Inserts in Patients With Diabetic Macular Edema
  ClinicalTrials.gov Identifier: NCT00490815 - Recruiting
  Diabetic Macular Edema
  
• Copaxone in Age Related Macular Degeneration
  ClinicalTrials.gov Identifier: NCT00466076 - Recruiting
  Macular Degeneration
  
• Improving Function in Age-Related Macular Degeneration
  ClinicalTrials.gov Identifier: NCT00572039 - Enrolling by invitation
  Age-Related Macular Degeneration
  
• Investigation of Macular Pigment Augmentation on Dark Adaptation
  ClinicalTrials.gov Identifier: NCT00478439 - Not yet recruiting
  Aging; Age-Related Macular Degeneration
  
• A Study of the Safety and Efficacy of SK-0503 for Diabetic Macular Edema
  ClinicalTrials.gov Identifier: NCT00308542 - Recruiting
  Diabetic Macular Edema
  
• The Role of Macular Pigment in Patients With Age-Related Macular Degeneration
  ClinicalTrials.gov Identifier: NCT00494325 - Recruiting
  Age Related Maculopathy
  
• Micropulse 810nm Diode Laser for Diffuse Diabetic Macular Edema
  ClinicalTrials.gov Identifier: NCT00552435 - Recruiting
  Diabetic Macular Edema
  
• Triamcinolone Acetonide as an Adjunctive to VPDT in ARMD.
  ClinicalTrials.gov Identifier: NCT00148551 - Active, not recruiting
  Age-Related Macular Degeneration
  
• Open-Label Posterior Juxtacleral Injections of Anecortave Acetate 15mg Dose for Long Term Use in Patients with AMD
  ClinicalTrials.gov Identifier: NCT00065728 - Recruiting
  Macular Degeneration
  
• A Phase 1, Safety, Tolerability and Pharmacokinetic Profile of Intravitreous Injections of E10030 (Anti-PDGF Pegylated Aptamer) in Subjects With Neovascular Age-Related Macular Degeneration
  ClinicalTrials.gov Identifier: NCT00569140 - Recruiting
  Age-Related Macular Degeneration
  
• A Study Using Intravitreal Injections of a Small Interfering RNA in Patients With Age-Related Macular Degeneration
  ClinicalTrials.gov Identifier: NCT00395057 - Recruiting
  Choroid Neovascularization; Age-Related Macular Degeneration
  
• The OMEGA Study: Use of Eye Drops to Treat Geographic Atrophy Associated With Age-Related Macular Degeneration (Dry AMD)
  ClinicalTrials.gov Identifier: NCT00485394 - Recruiting
  Age-Related Macular Degeneration